Materias dentro de su búsqueda.
Mostrando 121 - 140 Resultados de 312 Para Buscar '"Gavi"', tiempo de consulta: 0.22s Limitar resultados
  1. 121
    “…The demand forecast projected here is an upper bound estimate of vaccine demand, where actual demand depends on various factors such as country priorities, actual vaccine introduction, vaccination strategies, Gavi financing, costs, and overall product profile. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions
  2. 122
    “…Most of the vaccines were considerably cost-effective and only the Bivalent vaccine with the GAVI/UNICEF price which will be considered a cost-saving strategy.To provide national coverage of HPV vaccination in Indonesia, the government has to provide an annual budget of about US$49 million and US$22 million using the government contract price and GAVI/UNICEF price, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis
  3. 123
    “…Without Gavi support, ROTASIIL would have the lowest vaccine program cost (US$75.8 million) and 30 % probability of being cost-effective at the same threshold. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of rotavirus vaccination in Mozambique
  4. 124
    por Toor, Jaspreet, Echeverria-Londono, Susy, Li, Xiang, Abbas, Kaja, Carter, Emily D, Clapham, Hannah E, Clark, Andrew, de Villiers, Margaret J, Eilertson, Kirsten, Ferrari, Matthew, Gamkrelidze, Ivane, Hallett, Timothy B, Hinsley, Wes R, Hogan, Daniel, Huber, John H, Jackson, Michael L, Jean, Kevin, Jit, Mark, Karachaliou, Andromachi, Klepac, Petra, Kraay, Alicia, Lessler, Justin, Li, Xi, Lopman, Benjamin A, Mengistu, Tewodaj, Metcalf, C Jessica E, Moore, Sean M, Nayagam, Shevanthi, Papadopoulos, Timos, Perkins, T Alex, Portnoy, Allison, Razavi, Homie, Razavi-Shearer, Devin, Resch, Stephen, Sanderson, Colin, Sweet, Steven, Tam, Yvonne, Tanvir, Hira, Tran Minh, Quan, Trotter, Caroline L, Truelove, Shaun A, Vynnycky, Emilia, Walker, Neff, Winter, Amy, Woodruff, Kim, Ferguson, Neil M, Gaythorpe, Katy AM
    Publicado 2021
    “…FUNDING: VIMC is jointly funded by Gavi, the Vaccine Alliance, and the Bill and Melinda Gates Foundation (BMGF) (BMGF grant number: OPP1157270 / INV-009125). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
  5. 125
    “…In 2018, Senegal launched a national human papillomavirus (HPV) vaccination program with Gavi, the Vaccine Alliance (Gavi), support. HPV vaccination was incorporated into the national immunization program as a two-dose schedule, with a 6-12-month interval, to nine-year-old girls via routine immunization (RI) services at health facilities, schools and community outreach services throughout the year. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020
  6. 126
    “…The learnings would be beneficial for other countries yet to introduce critical new vaccines, in particular those with similar archetype as Indonesia e.g., middle-income countries with domestic manufacturing capacity and/or countries recently transitioning out of Gavi support.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022
  7. 127
    “…Côte d’Ivoire is in the Gavi preparatory transition phase, entering the accelerated transition phase in 2020, with an expected transition to full self-financing in 2025. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Trends of inequalities in childhood immunization coverage among children aged 12-23 months in Kenya, Ghana, and Côte d’Ivoire
  8. 128
    “…Guinea had the lowest BCR of 3·26 amongst the Gavi-eligible countries. Equatorial Guinea and Gabon had a narrow BCR of 1·86 and 2·06, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost–benefit analysis
  9. 129
    “…CONCLUSION: Our findings incorporate recent evidence that vaccine efficacy differs across locations, and support expansion of rotavirus vaccination programs, particularly in countries eligible for support from Gavi, The Vaccine Alliance.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis
  10. 130
    por Riedmann, Eva M.
    Publicado 2013
    “…Therapeutic HIV vaccine promising in the clinic GAVI aims to immunize 30 million against HPV by 2020 Self-destructing Salmonella to deliver oral DNA vaccines Novel strategy for vaccine design: Enzymatically modified antibodies GSK’s four-strain seasonal influenza vaccine approved in the US MVA85A TB vaccine tested in newborns of HIV-positive mothers Use of oral cholera vaccines promoted GSK partners with Vodafone to increase childhood vaccinatin in Mozambique…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Human Vaccines & Immunotherapeutics: News
  11. 131
    por Riedmann, Eva M.
    Publicado 2013
    “…Oncolytic vaccinia virus vaccine: Promising in liver cancer patients FDA panel endorses quadrivalent influenza vaccines Approval for the first meningitis B vaccine Stallergenes seeks FDA approval for sublingual grass-pollen allergy tablet Live-attenuated dengue vaccine promising in Phase 1 GAVI funds HPV vaccines for girls in developing countries First human trials for new superantigen bioterrorism vaccine Hexyon hexavalent pediatric vaccine recommended for approval…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Human Vaccines & Immunotherapeutics: News
  12. 132
    por Grundy, John, Biggs, Beverley-Ann
    Publicado 2018
    “…The 16 countries were selected because they had the largest numbers of registered UNHCR "persons of interest" and received new vaccine support from Global Alliance for Vaccine and Immunisation (GAVI), the Vaccine Alliance. We used national planning and reporting documentation including immunisation multiyear plans, health system strengthening strategies and GAVI annual progress reports (APRs) to assess the impact of conflict on immunisation access and coverage rates, and reviewed strategies developed to address immunisation program shortfalls in conflict settings. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Impact of Conflict on Immunisation Coverage in 16 Countries
  13. 133
    “…Vaccine spending from both the JRF and cMYP was higher than Gavi co-financing by a at least two (rho = 2.66, 95% 2.45 to 2.89) and (rho = 2.66, 95% 2.15 to 3.30), respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data
  14. 134
    por Rodgers, Gail L, Klugman, Keith P
    Publicado 2015
    “…Infection due to Streptococcus pneumoniae is a leading cause of morbidity and mortality in young children, especially in developing countries. With the support of Gavi, the Vaccine Alliance, the majority of these countries have introduced pneumococcal conjugate vaccines (PCV) into their national immunization programs and early data demonstrate a high degree of effectiveness, translating to enormous public health benefit through both direct and indirect (herd) effects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
  15. 135
    “…The World Health Organization (WHO) recommends the use of typhoid conjugate vaccines (TCV) in endemic settings and Gavi, the Vaccine Alliance, supports TCV introduction. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries
  16. 136
    “…BACKGROUND: Since 2012 Gavi, the Vaccine Alliance has provided financial support for HPV vaccine introduction in low- and middle-income countries (LMICs); however, funding has been contingent on establishing a demonstration project prior to national scale-up, in order to gauge effectiveness of delivery models. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR)
  17. 137
    “…The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17
  18. 138
    “…We stratified the analysis according to four groups based on their participation status in COVAX, from the highest to lowest income, that is, (1) fully self-financing high-income countries (group 1), (2) fully self-financing upper middle-income countries (group 2), (3) Advance Market Commitment (AMC) countries not eligible to receive Gavi support (group 3) and (4) AMC countries eligible for Gavi support (group 4). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020–2021
  19. 139
    “…He previously worked for the Expanded Programme on Immunisation in Cameroon and has been a consultant on vaccines and immunisation for WHO and the GAVI Alliance. Z. Waggie is a Paediatrician and Senior Clinical Research Officer at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Improving communication for immunisation in Africa: contribution of the Vaccines for Africa website
  20. 140
    “…With a newly World Health Organization (WHO)–prequalified typhoid conjugate vaccine (TCV), Gavi funding for eligible countries, and a WHO policy recommendation for TCV use, now is the time for countries to introduce TCVs as part of an integrated typhoid control program, particularly in light of the increasing burden of antimicrobial resistance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction
Herramientas de búsqueda: RSS